First Eagle Investment Management, LLC Cassava Sciences Inc Transaction History

First Eagle Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.04 - $1.45 $1.76 Million - $2.46 Million	-1,695,395 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$1.02 - $1.34 $801 - $1,053	-786 Reduced 0.05%	1,695,395 $2.05 Million
Q1 2019 May 13, 2019	BUY	$0.92 - $1.29 $1.56 Million - $2.19 Million	1,696,181 New	1,696,181 $2.19 Million

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Eagle Investment Management, LLC with notifications on news.